MHRA Drug Safety Update December 2021

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 5 December 2021) has been published and includes articles on:

  • Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
  • Venetoclax (Venclyxto▼): updated recommendations on tumour lysis syndrome (TLS)
  • Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus
  • COVID-19 vaccines and medicines: updates for December 2021
  • Letters and medicine recalls sent to healthcare professionals in November 2021

To see the latest MHRA Drug Safety Updates in full, visit the website